Free tool
Drug Trial Radar: Gastroenterology and liver
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
1
Not yet recruiting, industry sponsors, Gastroenterology and liver, Phase 4 (post-approval)
By trial status
The same filters, counted in each status. Pick one to switch.
1 trial
Showing 1 to 1, recently updated first.
- A Study to Evaluate Tegoprazan as a Diagnostic Tool for GERDPivotal-lookingNot yet recruiting
HK inno.N CorporationIndustry
NCT07826455 · 100 participants (planned) · Start Sep 1, 2026 · Primary completion Jul 31, 2028
Drug: Tegoprazan 50 mg; Placebo · For: GERD (Gastroesophageal Reflux Disease)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.